Apyx Medical (APYX) Debt to Equity (2016 - 2025)
Historic Debt to Equity for Apyx Medical (APYX) over the last 14 years, with Q3 2025 value amounting to $5.69.
- Apyx Medical's Debt to Equity rose 8826.3% to $5.69 in Q3 2025 from the same period last year, while for Sep 2025 it was $5.69, marking a year-over-year increase of 8826.3%. This contributed to the annual value of $2.36 for FY2024, which is 9181.29% up from last year.
- Per Apyx Medical's latest filing, its Debt to Equity stood at $5.69 for Q3 2025, which was up 8826.3% from $4.61 recorded in Q2 2025.
- Apyx Medical's Debt to Equity's 5-year high stood at $5.69 during Q3 2025, with a 5-year trough of $0.24 in Q2 2023.
- In the last 3 years, Apyx Medical's Debt to Equity had a median value of $2.25 in 2024 and averaged $2.25.
- In the last 5 years, Apyx Medical's Debt to Equity soared by 102713.82% in 2024 and then skyrocketed by 8826.3% in 2025.
- Apyx Medical's Debt to Equity (Quarter) stood at $1.23 in 2023, then skyrocketed by 91.81% to $2.36 in 2024, then soared by 140.74% to $5.69 in 2025.
- Its Debt to Equity stands at $5.69 for Q3 2025, versus $4.61 for Q2 2025 and $3.21 for Q1 2025.